Monday, November 23, 2026
News

Zydus gets US FDA final nod for Febuxostat tablets for treating high uric acid

SocialTwist Tell-a-Friend    Print this Page   COMMENT

Ahmedabad (Gujarat) | January 15, 2023 4:33:05 PM IST
Zydus Lifesciences has said it has received final approval from the US Food and Drug Administration (US FDA) to market Febuxostat tablets for 40 mg and 80 mg.

According to the statement from Zydus, Febuxostat tablets are indicated to lower hyperuricemia (high uric acid in the blood) in patients with gout who have been treated with allopurinol that did not work well or cannot be treated with allopurinol.

Zydus said the drug would be manufactured at the group's formulation manufacturing facility at Moraiya, Ahmedabad, India. Allopurinol is a medication used to decrease high blood uric acid levels.

Febuxostat tablets had annual sales of USD 32 million in the US, according to IQVIA data for September.

The group now has got 340 approvals and has so far filed over 431 abbreviated new drug applications (ANDAs).

Leading Indian pharmaceutical company Zydus Lifesciences, formerly known as Cadila Healthcare, is a fully integrated, global health care provider. With in-depth domain expertise in the field of healthcare, it has strong capabilities across the spectrum of the pharmaceutical value chain. (ANI)

 
  LATEST COMMENTS (0)
POST YOUR COMMENT
Comments Not Available
 
POST YOUR COMMENT
 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
 
MORE BUSINESS NEWS
Maruti Suzuki hikes prices of select mod...
Jewellers encouraged old-gold exchanges ...
Government, corporate spending to sustai...
Cotton import allowances are in place un...
Asia, Africa to drive expansion of India...
Grid constraints, slower project awards ...
More...
 
INDIA WORLD ASIA
'Lotus will bloom in 2027, SP-Congress w...
Karnataka CM DK Shivakumar visits Japan ...
Sabrimala administration imposes strict ...
'Deeply painful': PM Modi announces Rs 2...
CJI Suryakant welcomes judicial reforms,...
JK: Fire breaks out in three-storey buil...
More...    
 
 Top Stories
"There is NO ONE like you": Actor D... 
It attracts fresh and budding talen... 
La Liga: Barcelona stage comeback t... 
US: Automation glitch triggers grou... 
South Asia, Sub-Saharan Africa play... 
MS Dhoni, Muttiah Muralitharan, Kan... 
Maharashtra Dy CM Sunetra Pawar rev... 
Carlos Alcaraz draws level with Jan...